...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: An interaction with central angiotensin II receptors.
【24h】

Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: An interaction with central angiotensin II receptors.

机译:慢性主动脉缩窄性高血压大鼠的下丘脑前β-肾上腺素受体:与中央血管紧张素II受体的相互作用。

获取原文
获取原文并翻译 | 示例

摘要

SUMMARY 1. The aim of the present study was to investigate the activity of anterior hypothalamic beta-adrenoceptors and angiotensin (Ang) II receptors on blood pressure in normotensive rats and aortic-coarctated (ACo) animals at a chronic stage of hypertension. A possible interaction between beta-adrenoceptors and AngII pressor activity was also investigated. 2. Injection of isoproterenol (0.1-10 nmol) in the anterior hypothalamic area induced a dose-dependent decrease in mean arterial pressure (MAP) in sham-operated (SO), but not in ACo, animals. Isoproterenol (1 nmol) reduced blood pressure in SO rats (DeltaMAP -10.1 +/- 1.4 mmHg; n = 10) but not in ACo animals (DeltaMAP -0.9 +/- 1.6 mmHg; n = 10; P < 0.05 vs SO rats). Whereas previous administration of atenolol (40 nmol) enhanced the cardiovascular effect of isoproterenol (1 nmol) in ACo rats but not in SO animals, propranolol (40 nmol) prevented the hypotensive action of isoproterenol in both experimental groups. Intrahypothalamic administration ofclenbuterol decreased MAP in a dose-dependent manner; however, the depressor response to clenbuterol (10 nmol) was greater in ACo rats than in SO rats (DeltaMAP -26.8 +/- 3.2 vs-14.4 +/- 2.4 mmHg, respectively; n = 5 for both; P < 0.05). When AngII (50 ng) was injected into the anterior hypothalamic area, a greater pressor response was observed in ACo rats than in SO rats (DeltaMAP 19.6 +/- 1.1 vs 11.3 +/- 0.6 mmHg, respectively; n = 5 for both; P < 0.05). Atenolol (40 nmol) pretreatment partially and significantly prevented the pressor response to AngII in ACo rats, but not in SO rats. 3. In conclusion, these results provide pharmacological evidence for the existence of a beta(1)-adrenoceptor-mediated pressor mechanism in the anterior hypothalamic area of ACo rats that is absent in SO rats. The enhanced depressor beta(2)-adrenoceptor activity observed in chronic ACo rats could be a compensatory adjustment to pressor beta(1)-adrenoceptor activity. Conversely, pressor overactivity of AngII was observed in the anterior hypothalamic area of ACo rats at a chronic hypertensive stage; this enhancement could be explained, at least in part, by the pressor beta(1)-adrenoceptor activity.
机译:概述1.本研究的目的是研究在慢性高血压的正常血压大鼠和主动脉缩窄(ACo)动物中下丘脑前β-肾上腺素受体和血管紧张素(Ang)II受体对血压的活性。还研究了β-肾上腺素能受体与AngII升压活性之间可能的相互作用。 2.在下丘脑前部区域注射异丙肾上腺素(0.1-10 nmol)可以在假手术(SO)动物中引起平均动脉压(MAP)的剂量依赖性降低,但在ACo动物中则不然。异丙肾上腺素(1 nmol)可降低SO大鼠的血压(DeltaMAP -10.1 +/- 1.4 mmHg; n = 10),但不降低ACo动物的血压(DeltaMAP -0.9 +/- 1.6 mmHg; n = 10; P <0.05 )。先前给予阿替洛尔(40 nmol)在ACo大鼠中增强了异丙肾上腺素(1 nmol)的心血管作用,但未对SO动物产生心血管作用,而普萘洛尔(40 nmol)在两个实验组中均阻止了异丙肾上腺素的降压作用。盐酸克仑特罗的下丘脑内给药以剂量依赖性方式降低了MAP。然而,ACo大鼠对克仑特罗(10 nmol)的抑制作用要比SO大鼠高(分别为DeltaMAP -26.8 +/- 3.2 vs-14.4 +/- 2.4 mmHg;两者均为n = 5; P <0.05)。当将AngII(50 ng)注入下丘脑前区时,在ACo大鼠中观察到了比SO大鼠更大的升压反应(分别为DeltaMAP 19.6 +/- 1.1和11.3 +/- 0.6 mmHg;两者均为n = 5; P <0.05)。阿替洛尔(40 nmol)预处理在ACo大鼠中部分且显着阻止了对AngII的升压反应,但在SO大鼠中没有。 3.总之,这些结果提供了ACO大鼠下丘脑前区中β(1)-肾上腺素受体介导的加压机制的存在的药理证据,而SO大鼠中不存在。慢性ACo大鼠中观察到的增强的降压β(2)-肾上腺素受体活性可能是对升压β(1)-肾上腺素受体活性的补偿性调节。相反,在慢性高血压阶段,ACo大鼠的下丘脑前部区域观察到了AngII的升压过度活动。这种增强可以至少部分地通过加压β(1)-肾上腺素受体活性来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号